Atherosclerosis
Volume 183, Issue 1 , Pages 35-39 , November 2005

Glimepiride induces nitric oxide production in human coronary artery endothelial cells via a PI3-kinase-Akt dependent pathway

Received 4 January 2004 ,Revised 10 January 2005 ,Accepted 12 January 2005.

References 

  1. Bierman E. George Lyman Duff Memorial Lecture. Atherogenesis in diabetes. Arterioscler Thromb. 1992;12(6):647–656
  2. Laakso M, Lehto S. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis. 1998;137(Suppl.):65–73
  3. Woodfield S, Lundergan C, Reiner J, et al. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol. 1996;28(7):1661–1669
  4. del Valle H, Lascano E, Negroni J, Crottogini AJ. Glibenclamide effects on reperfusion-induced malignant arrhythmias and left ventricular mechanical recovery from stunning in conscious sheep. Cardiovasc Res. 2001;50(3):474–485
  5. Geisen K, Vegh A, Krause E, Papp JG. Cardiovascular effects of conventional sulfonylureas and glimepiride. Horm Metab Res. 1996;28(9):496–507
  6. Riveline J, Danchin N, Ledru F, Varroud-Vial M, Charpentier G. Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications. Diab Metab. 2003;29(3):207–222
  7. Shakuto S, Sato Y, Ohshima K, Yaguchi M. Atheroprotective effects of a new sulfonylurea of the third generation, glimepiride. Diabetic Complications. 2001;15(Suppl. 1):68
  8. Muller G, Jung C, Wied S, Welte S, Frick W. Insulin-mimetic signaling by the sulfonylurea glimepiride and phosphoinositolglycans involves distinct mechanisms for redistribution of lipidraft components. Biochemistry. 2001;40(48):14603–14620
  9. Maejima Y, Ueba H, Kuroki M, et al. Src family kinases and nitric oxide production are required for hepatocyte growth factor-stimulated endothelial cell growth. Atherosclerosis. 2003;167(1):89–95
  10. Hiraoka A, Masuya Y, Tominaga I. Simultaneous determination by high-performance liquid chromatography of nitrite and nitrate in cerebrospinal fluid and serum from patients with neurological disorders. Chromatography. 1999;20(1):45–49
  11. Ueba H, Poppa V, Suero J, Okuda M, Berk BC. c-Src is required for flow-stimulated NO production in bovine aortic endothelial cells. Circulation. 1998;98(17):I-312
  12. Gallis BCG, Goodlett DR, Ueba H, et al. Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J Biol Chem. 1999;274(42):30101–30108
  13. Aengevaeren W. Beyond lipids—the role of the endothelium in coronary artery disease. Atherosclerosis. 1999;147(Suppl. 1):11–16
  14. Fulton D, Gratton J, McCabe TJ, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 1999;399(6736):597–601
  15. Skaletz-Rorowski A, Lutchman M, Kureishi Y, Lefer D, Faust J, Walsh K. HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells. Cardiovasc Res. 2003;57(1):253–264
  16. Song DK, Ashcroft FM. Glimepiride block of cloned beta-cell, cardiac and smooth muscle K (ATP) channels. Br J Pharmacol. 2001;133(1):193–199
  17. Muller G, Jung C, Frick W, Bandlow W, Kramer W. Interaction of phosphatidylinositolglycan(-peptides) with plasma membrane lipid rafts triggers insulin-mimetic signaling in rat adipocytes. Arch Biochem Biophys. 2002;408(1):7–16
  18. Peterson TE, Poppa V, Ueba H, Wu A, Yan C, Berk BC. Opposing effects of reactive oxygen species and cholesterol on endothelial NO synthase and endothelial cell caveolae. Circ Res. 1999;85:29–37

PII: S0021-9150(05)00168-1

doi: 10.1016/j.atherosclerosis.2005.01.055

Atherosclerosis
Volume 183, Issue 1 , Pages 35-39 , November 2005

Article Tools

* Image Usage & Resolution